- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
How Has COVID-19 Impacted the Allergy and Immunology Field?
Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.
With unprecedented pauses in air pollution emissions seen around the world in the spring of 2020 and virus mitigation behaviors being implemented for over a year, the COVID-19 pandemic has presented a unique opportunity to better understand the impact of poor air quality on human health.
In particular, exposure reduction due to mask-wearing and stay-at-home orders has contributed to anecdotal reports of reduced exacerbations among patients with chronic obstructive pulmonary disease (COPD), asthma, allergies, and other respiratory conditions.
To learn more about how the pandemic has altered care and disease management among these patients, we spoke with Courtney Blair, MD, an allergist and immunologist in Virginia.
On this episode of Managed Care Cast, Blair, who also serves as the president of the Greater Washington Allergy, Asthma, and Immunology Society, discusses factors that may have contributed to improvements in her patients’ respiratory health over the past 15 months.
Listen above or through one of these podcast services:
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
August 9th 2025Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and development are necessary to fully realize its potential in clinical practice.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More
